Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the effects of a naturally occurring hormone in the body. By stimulating GLP-1 receptors, Semaglutide enhances insulin secretion, reduces glucagon levels, and slows gastric emptying. These actions contribute to decreased appetite and prolonged feelings of fullness, which help reduce overall calorie intake. Semaglutide essentially helps keep you from feeling hungry too soon. This means you're less likely to overeat, supporting steady weight loss.
Tirzepatide
Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist. By activating these receptors, Tirzepatide enhances insulin sensitivity, suppresses appetite, and delays gastric emptying. This dual action results in reduced hunger and increased satiety, making it easier to adhere to a calorie-controlled diet. The delayed gastric emptying also helps in managing post-meal blood sugar levels, contributing to more effective weight management and long-term weight loss success.